Synergetics USA (SURG) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Synergetics Reports Second Quarter of Fiscal Year 2015 Results
March 10, 2015 4:05 PM EDTO'FALLON, MO -- (Marketwired) -- 03/10/15 -- Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today announced results for the second quarter of fiscal year 2015.
Second Quarter Summary:
Total sales were $18.2 million, an increase of 20.5% year-over-year. Excluding the impacts of the acquisition of Sterimedix in the period, total sales increased 13.4% year-over-year. Ophthalmic sales increased 8.9% year-over-year and neurosurgery sales increased 36.4% year-over-year. Domestic sales increased 16.6% and International sales increased 31.0% year-over-year. International sales increased 36.8% year-over-year on a constant currency... More